We've found
4,132 Diabetes
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Orthopedics / Podiatry, Other Clinical Trial
Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Enhanced Quality in Primary Care for Elders With Diabetes and Dementia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Orthopedics / Podiatry Clinical Trial
A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Pompe Lactation Sub-Registry
Status: Enrolling,
Phase
IV
Updated: 12/21/2017
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling,
Phase
III
Updated: 4/8/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling,
Phase
III
Updated: 4/8/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
We've found
4,132 Diabetes
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Updated: 12/31/1969
Enhanced Quality in Primary Care for Elders With Diabetes and Dementia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/21/2017
Pompe Lactation Sub-Registry
Status: Enrolling,
Phase
IV
Updated: 12/21/2017
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
Updated: 2/27/2009
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
Updated: 2/27/2009
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
Updated: 2/27/2009
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
Updated: 2/27/2009
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Endocrinology, Immunology / Infectious Diseases, Other Clinical Trial
Updated: 2/27/2009
A Complicated Skin and Soft-Tissue Infection Patient Registry
Status: Enrolling
Updated: 2/27/2009
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/22/2017
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/22/2017
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/22/2017
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/22/2017
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/22/2017
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Status: Enrolling,
Phase
IV
Updated: 12/22/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Updated: 12/31/1969
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Updated: 12/31/1969
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Updated: 12/31/1969
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 4/8/2015
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling,
Phase
III
Updated: 4/8/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 4/8/2015
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling,
Phase
III
Updated: 4/8/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials